Combined Therapy against Recurrent Hemangiopericytoma: A Case Report

por Li, Xiao-dong, Jiang, Jing-ting, Wu, Chang-ping
Publicado 2012

Mechanism of T cell regulation by microRNAs

por Liu, Juan, Wu, Chang-Ping, Lu, Bin-Feng, Jiang, Jing-Ting
Publicado 2013

Would foot arch development in children characterize a body maturation process? A prospective longitudinal study

por Chang, Chia-Hsieh, Yang, Wen-Tien, Wu, Chang-Ping, Chang, Liang-Wey
Publicado 2022

Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China

por Li, Xiao-Dong, Wu, Chang-Ping, Ji, Mei, Wu, Jun, Lu, Binfeng, Shi, Hong-Bing, Jiang, Jing-Ting
Publicado 2013

CD40 mutant expression and its clinical significance to prognosis in gastric cancer patients

por Zhao, Wei-Qing, Li, Xiao-Dong, Shi, Hong-Bing, Wu, Jun, Zhao, Jie-Min, Ji, Mei, Wu, Chang-Ping
Publicado 2014

Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors

por Li, Xiao-Dong, Ji, Mei, Zheng, Xiao, Ning, Zhong-Hua, Wu, Jun, Lu, Binfeng, Wu, Chang-Ping, Jiang, Jing-Ting
Publicado 2014

PD-1/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation

por Ji, Mei, Liu, Yan, Li, Qing, Li, Xiao-Dong, Zhao, Wei-Qing, Zhang, Hanze, Zhang, Xiaofei, Jiang, Jing-Ting, Wu, Chang-Ping
Publicado 2015

The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial–mesenchymal transition via METTL3-mediated N6-methyladenosine modification...

por Ni, Xue-Feng, Xie, Quan-Qin, Zhao, Jie-Min, Xu, Yan-jie, Ji, Mei, Hu, Wen-Wei, Wu, Jun, Wu, Chang-Ping
Publicado 2021

Cytokine-induced killer cells co-cultured with dendritic cells loaded with the protein lysate produced by radiofrequency ablation induce a specific antitumor response

por SHAN, CHAN-CHAN, SHI, LIANG-RONG, DING, MEI-QIAN, ZHU, YI-BEI, LI, XIAO-DONG, XU, BIN, JIANG, JING-TING, WU, CHANG-PING
Publicado 2015

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical trial

por Xu, Rui-Hua, Shen, Lin, Wang, Ke-Ming, Wu, Gang, Shi, Chun-Mei, Ding, Ke-Feng, Lin, Li-Zhu, Wang, Jin-Wan, Xiong, Jian-Ping, Wu, Chang-Ping, Li, Jin, Liu, Yun-Peng, Wang, Dong, Ba, Yi, Feng, Jue-Ping, Bai, Yu-Xian, Bi, Jing-Wang, Ma, Li-Wen, Lei, Jian, Yang, Qing, Yu, Hao
Publicado 2017

A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung c...

por Liu, Ke-Jun, Guan, Zhong-Zhen, Liang, Ying, Yang, Xu-Qing, Peng, Jin, Huang, He, Shao, Qing-Xiang, Wang, Meng-Zhao, Zhu, Yun-Zhong, Wu, Chang-Ping, Wang, Shao-Bin, Xiong, Jian-Ping, Bai, Yu-Xian, Yu, Shi-Ying, Zhang, Yang, Hu, Xiao-Hua, Feng, Ji-Feng, Wu, Shi-Xiu, Jiao, Shun-Chang, Zhou, Cai-Cun, Wang, Jie, Wu, Hai-Ying
Publicado 2014

Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World C...

por Wu, Jian-Qiu, Song, Yong-Ping, Su, Li-Ping, Zhang, Ming-Zhi, Li, Wei, Hu, Yu, Zhang, Xiao-Hong, Gao, Yu-Huan, Niu, Zuo-Xing, Feng, Ru, Wang, Wei, Peng, Jie-Wen, Li, Xiao-Lin, Ouyang, Xue-Nong, Wu, Chang-Ping, Zhang, Wei-Jing, Zeng, Yun, Xiao, Zhen, Liang, Ying-Min, Zhuang, Yong-Zhi, Wang, Ji-Shi, Sun, Zi-Min, Bai, Hai, Cui, Tong-Jian, Feng, Ji-Feng
Publicado 2018